Investment Type: Accelerator
Investment Stage: Seed
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 25.02.2026 | Myrias Opt... | myriasoptics.com | $5.1M | United Sta... |
| 17.02.2026 | GelMEDIX, ... | gelmedix.com | $13M | United Sta... |
Mentions in press and media 9
| Date | Title | Description |
| 27.02.2026 | Myrias Optics Fuels Wafer-Level Metaoptics Revolution with $2.1M Seed 1 Funding | Myrias Optics secured $2.1 million in Seed 1 financing. This capital propels wafer-level metaoptics commercialization. The company's proprietary all-inorganic nanoimprint platform delivers durable, high-performance optical components. This ... |
| 25.02.2026 | Myrias Optics Raises $2.1 in Seed 1 Funding | Myras Optics, an Amherst, MA-based wafer-level metaoptics and diffractive optical technologies company, raised $2.1M in Seed 1 funding. The round was led by MassVentures, with participation from existing investors Hoss Investment, Maroon Ve... |
| 24.02.2026 | Myrias Optics: $2.1 Million Seed 1 Financing To Accelerate Commercialization Of Wafer-Level Metaoptics | Myrias Optics has closed a $2.1 million Seed 1 financing round to accelerate the commercialization of its wafer-level metaoptics and diffractive optical technologies. The round, completed in January 2026, was led by MassVentures, with parti... |
| 23.02.2026 | GelMEDIX Secures $13 Million to Advance Vision Restoration | GelMEDIX, a biotechnology innovator, closed a $13 million seed funding round. Safar Partners spearheaded the investment. This capital fuels the company's lead program, GMX-101. GMX-101 targets late-stage Geographic Atrophy, a devastating fo... |
| 17.02.2026 | GelMEDIX Raises $13M in Seed Funding | GelMEDIX, a Cambridge, MA-based biotechnology company developing regenerative therapies to restore vision, raised $13M in Seed funding. The round was led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels, TiE Bosto... |
| 17.02.2026 | GelMEDIX: $13 Million Seed Funding Closed For Vision Restoration Biotechnology Platform | GelMEDIX, a biotechnology company developing regenerative therapies to restore vision, has completed a $13 million seed financing round led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels, TiE Boston Angels, Bost... |
| 06.12.2016 | Unpitch Is Back, Because We Still Need It | In these times of discord in America, most people still seem to agree on one thing: if you want to launch a company, you need to find some money. And the more time you spend around startups, the more it seems everyone also agrees that the k... |
| 31.01.2012 | You Stopped SOPA. Now Let’s Startup America | Note from the editor: This is a guest post from Steve Case, the co-founder of AOL (which owns TechCrunch) and founder of Revolution. Case is the chairman of the Startup America Partnership and sits on the White House Jobs Council. In recent... |
| 25.01.2011 | TiE Boston Announces Angel Investing Group | Share Share on Facebook Share on Twitter LinkedIn Email Reprints There’s a new angel investing group in town, and this one is tied to a global organization supporting entrepreneurship. TiE Boston, the local chapter of The Indus Entrepreneur... |